Skip to main content

Muskeldystrophien, Myotonien und metabolische Myopathien Bearbeitet

  • Chapter
Klinische Neurologie

Zusammenfassung

Muskeldystrophien bilden eine klinisch und genetisch heterogene Gruppe primär degenerativer, progressiver Muskelerkrankungen. Das Manifestationsalter reicht von der frühen Kindheit bis in das mittlere und späte Erwachsenenalter. Bei vielen Formen ist inzwischen der zugrundeliegende Genort, bei einigen Formen auch das defekte Genprodukt bekannt. Dies hat zu einer neuen Klassifikation der Muskeldystrophien geführt.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 54.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Similar content being viewed by others

Literatur

Zitierte Literatur

  • Amit R, Bashan N, Abarbanel JM et al. (1992) Fatal familial infantile glycogen storage disease: multisystem phosphofruc-tokinase deficiency. Muscle Nerve 15:455–458

    Article  PubMed  CAS  Google Scholar 

  • Danon MJ, Carpenter S, Manaligod JR, Schliselfeld LH (1981) Fatal infantile glycogen storage disease: deficiency of phos-phofructokinase and Phosphorylase b kinase. Neurology 31:1303–1307

    Article  PubMed  CAS  Google Scholar 

  • Danon MJ, Servidei S, DiMauro S, Vora S (1988) Late-onset muscle phosphofructokinase deficiency. Neurology 38: 956–960

    Article  PubMed  CAS  Google Scholar 

  • DiMauro S, Tsujino S (1994) Nonlysosomal glycogenoses. In: Engel AG, Franzini-Armstrong C (eds) Myology, vol 2. McGraw-Hill, New York, pp 1554–1576

    Google Scholar 

  • Fishbein WN (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33:158–169

    Article  PubMed  CAS  Google Scholar 

  • Guibaud P, Carrier H, Mathieu M et al. (1978) Observation familiale de dystrophic musculaire congenitale par deficit en phosphofructokinase. Arch Pediatr 35:1105 – 1115

    CAS  Google Scholar 

  • Haller RG, Lewis SF (1991) Glucose-induced exertional fatigue in muscle phosphofructokinase deficiency. N Engl J Med 324:364–369

    Article  PubMed  CAS  Google Scholar 

  • Hays AP, Hallet M, Delfs J et al. (1981) Muscle phosphofructokinase deficiency: abnormal polysaccharide in a case of late-onset myopathy. Neurology 31:1077–1086

    Article  PubMed  CAS  Google Scholar 

  • Hers HG, Van Hoof F, Barsy T de (1989) Glycogen storage disease. In: Scriver CR, Beaudet N, Sly WS, Valle D (eds) The metabolic basis of inherited disease. McGraw-Hill, New York, pp 425–452

    Google Scholar 

  • Ricker K, Koch MC, Lehmann-Horn F, Pongratz D Otto M, Heine R, Moxley RT (1994) Proximal myotonic myopathy: A new dominant disorder with myotonia, muscle weakness, and cataracts. Neurology 44:1448–1452

    Article  PubMed  CAS  Google Scholar 

  • Serratrice G, Monges A, Roux H et al. (1969) Forme myopathique du deficit en phosphofructokinase. Rev Neurol 34:271–277

    Google Scholar 

  • Servidei S, Bonilla E, Diedrich RG et al. (1986) Fatal infantile form of muscle phosphofructokinase deficiency. Neurology 36:1465–1470

    Article  PubMed  CAS  Google Scholar 

  • Zierz S (1994) Carnitine palmitoyltransferase deficiency. In: Engel AG, Franzini-Armstrong C (eds) Myology, vol 2. Mc Graw-Hill, New York, pp 1577–1586

    Google Scholar 

  • Zierz S, Engel AG (1985) Regulatory properties of a mutant carnitine palmitoyl transferase in human skeletal muscle. Eur J Biochem 149: 207–214

    Article  PubMed  CAS  Google Scholar 

Weiterführende Literatur

  • Barohn RJ, Miller RG, Griggs RC (1991) Autosomal recessive distal dystrophy. Neurology 41:1365 – 1370

    Article  PubMed  CAS  Google Scholar 

  • Brais B, Xie YG, Sanson M (1995) The oculopharyngeal muscular dystrophy locus maps to the region of the cardiac aand ßmyosin heavy chain genes on chromosome 14qll.2-ql3. Hum Mol Genet 4:429 – 434

    Article  PubMed  CAS  Google Scholar 

  • Brevister B, Groenen P, Wieringa B (1998) Myotonic dystrophy: clinical and molecular aspects. In: Emery AEH (ed) Neuromuscular disorders: clinical and molecular genetics. Wiley & Sons, Chichester, pp 323 – 364

    Google Scholar 

  • Brook JD, McCurrach ME, Harley HG et al. (1992) Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3’end of a transcript encoding a protein kinase family member. Cell 68: 799–808

    Article  PubMed  CAS  Google Scholar 

  • Campbell KP (1995) Three muscular dystrophies: loss of cytoskeleton-extracellular matrix linkage. Cell 80: 675–679

    Article  PubMed  CAS  Google Scholar 

  • Cox GF, Kunkel LM (1997) Dystrophies and heart disease. Curr Opin Cardiol 12: 329–343

    Article  PubMed  CAS  Google Scholar 

  • Davies KE (1997) Challenges in Duchenne muscular dystrophy. Neuromuscul Disord 7:482 – 486

    Article  PubMed  CAS  Google Scholar 

  • DiMauro S (1997) Mitochondrial encephalomyopathies. In: Rosenberg RN, Prusiner SB, DiMauro S, Barchi RL (eds) The molecular and genetic basis of neurological diseases. Butterworth-Heinemannn, Boston Wellington, S 201–235

    Google Scholar 

  • Eger K, Schulte-Mattler WJ, Zierz S (1997) Proximale myotone Myopathie (PROMM). Nervenarzt 68: 839–844

    Article  PubMed  CAS  Google Scholar 

  • Emery AEH (ed) (1997) Diagnostic criteria for neuromuscular disorders, 2nd edn. Royal Society of Medicine, London

    Google Scholar 

  • Emery AEH (ed) (1998) Neuromuscular disorders: clinical and molecular genetics. Wiley & Sons, Chichester

    Google Scholar 

  • Engel A, Franzini-Armstrong C (eds) (1994) Myology, 2nd edn, vol 1 and 2. McGraw-Hill, New York

    Google Scholar 

  • Finsterer J (1997) Mitochondriopathien. Akt Neurologie 24: 231–241

    Article  Google Scholar 

  • Goto YI, Nonaka I, Horai S (1990) A mutation in the tRNA-Leu(UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651 – 653

    Article  PubMed  CAS  Google Scholar 

  • Harper PS (1989) Myotonic dystrophy, 2nd edn. Saunders, Philadelphia

    Google Scholar 

  • Hirano M, Ricci E, Koenigsberger MR et al. (1992) MELAS: an original case and clinical criteria for diagnosis. Neuromus-cul Disord 2:125–135

    Article  CAS  Google Scholar 

  • Jackson MJ, Schaefer JA, Johnson MA, Morris AAM, Turnbull DM, Bindoff LA (1995) Presentation and clinical investigation of mitochondrial respiratory chain disease. Brain 118: 339–357

    Article  PubMed  Google Scholar 

  • Jerusalem F, Zierz S (1991) Muskelerkrankungen, 2. Aufl. Thieme, Stuttgart

    Google Scholar 

  • Kakulas BA (1996) The differential diagnosis of the human dystrophinopathies and related disorders. Curr Opin Neurol 9:380–388

    Article  PubMed  CAS  Google Scholar 

  • Lehmann-Horn F, Engel AG, Ricker K, Rudel R (1994) The periodic paralyses and paramyotonia congenita. In: Engel AG, Franzini-Armstrong (eds) Myology, vol 2. McGraw-Hill, New York, pp 1303–1334

    Google Scholar 

  • Lehmann-Horn F, Mailander V, Heine R, George AL (1995) Myotonia levior is a chloride channel disorder. Hum Mol Genet 4:1397–1402

    Article  PubMed  CAS  Google Scholar 

  • Lim LE, Campbell KP (1998) The sarcoglycan complex in limb-girdle muscular dystrophy. Curr Opin Neurol 11:443 – 452

    Article  PubMed  CAS  Google Scholar 

  • Liu J, Aoki M, Ilia I et al. (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20: 31 – 36

    Article  PubMed  CAS  Google Scholar 

  • Manilal S, Recan D, Sewry CA et al. (1998) Mutations in Emery-Dreifuss muscular dystrophy and their effects on emerin protein expression. Hum Mol Genet 7: 855–864

    Article  PubMed  CAS  Google Scholar 

  • Meyer-Kleine C, Steinmeyer K, Ricker K, Jentsch T, Koch MC (1995) Spectrum of mutations in the major human skeletal muscle chloride channel gene (CLCNI) leading to myotonia. Am J Hum Genet 57: 1325–1334

    PubMed  CAS  Google Scholar 

  • Mortier W (1994) Muskel- und Nervenerkrankungen im Kindesalter. Thieme, Stuttgart New York

    Google Scholar 

  • Pongratz DE, Reimers CD, Hahn D, Nägele M, Müller-Felber W (1990) Atlas der Muskelkrankheiten. Urban & Schwarzen-berg, München

    Google Scholar 

  • Ricker K, Koch MC, Lehmann-Horn F, Pongratz D, Speich N, Reiners K, Schneider C, Moxley RT (1995) Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 52: 25–31

    Article  PubMed  CAS  Google Scholar 

  • Riordan-Eva P, Wood NW (1996) Mitochondrial disorders in neuro-ophthalmology. Curr Opin Neurol 9:1–4

    Article  PubMed  CAS  Google Scholar 

  • Rosenfeld J, Sloanbrown K, George AL (1997) A novel muscle sodium channel mutation causes painful congenital myotonia. Ann Neurol 42:811–814

    Article  PubMed  CAS  Google Scholar 

  • Rudel R, Lehmann-Horn F (1998) Muscle ion channel diseases: non-dystrophic myotonias, periodic paralyses, and malignant hyperthermia. In: Emery AEH (ed) Neuromuscular disorders: clinical and molecular genetics. Wiley & Sons, Chichester, pp 365 – 420

    Google Scholar 

  • Schapira AHV, DiMauro S (eds) (1994) Mitochondrial disorders in Neurology. Butterworth-Heinemann, Oxford

    Google Scholar 

  • The FSH-DY Group (1997) A prospective, quantitative study of the natural history of facioscapulohumeral muscular dystrophy (FSHD): implications for therapeutic trials. Neurology 48:38–46

    Article  Google Scholar 

  • Voit T, Krogmann O, Lenard HG et al. (1988) Emery-Dreifuss muscular dystrophy: disease spectrum and differential diagnosis. Neuropediatrics 19:62–71

    Article  PubMed  CAS  Google Scholar 

  • Wallace DC, Singh G, Lott MT (1988) Mitochondrial DNA mutation associated with Leber’s hereditary optic neuropathy. Science 242:1427–1430

    Article  PubMed  CAS  Google Scholar 

  • Wallgren-Petterson C (1998) Genetics of the Nemaline myopathies and the myotubular myopathies. Neuromuscul Disord 8:401–404

    Article  Google Scholar 

  • Wewer UM, Engvall E (1996) Merosin/Laminin-2 and muscular dystrophy. Neuromuscul Disord 6:409 – 418

    Article  PubMed  CAS  Google Scholar 

  • Wijmenga C, Frants RR, Brouwer OF et al. (1990) Location of facioscapulohumeral muscular dystrophy gene on chromosome 4. Lancet 336: 651–653

    Article  PubMed  CAS  Google Scholar 

  • Zierz S, Jerusalem F (1989) Mitochondriale Myopathien und Enzephalomyopathien. Nervenarzt 60:394 – 400

    PubMed  CAS  Google Scholar 

  • Zierz S, Meeßen S, Jerusalem F (1989) Laktat- und Pyruvat-blutspiegel in der Diagnostik mitochondrialer Myopathien. Nervenarzt 60: 545–548

    PubMed  CAS  Google Scholar 

  • Zierz S, Wersebe O von, Gerbitz KD, Jerusalem F (1990) Ophthalmoplegia plus: klinische Variabilität, biochemische Defekte der mitochondrialen Atmungskette und Deletionen des mitochondrialen Genoms. Nervenarzt 61: 332–339

    PubMed  CAS  Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1999 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Eger, K., Schulte-Mattler, W.J., Hertel, K., Deschauer, M., Lindner, A., Zierz, S. (1999). Muskeldystrophien, Myotonien und metabolische Myopathien Bearbeitet. In: Berlit, P. (eds) Klinische Neurologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-08118-1_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-08118-1_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-08119-8

  • Online ISBN: 978-3-662-08118-1

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics